Anlon Healthcare Ltd.

•

anlon.inBSE: 544497NSE: AHCL

Market Cap₹ 833 Cr.

Current Price

High / Low₹ 17 / 9

Stock P/E28.7

Book Value₹ 5

Price to Book2.82

Dividend Yield0.00 %

ROCE22.4 %

ROE19.2 %

Face Value₹ 2

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Company has a good return on equity (ROE) track record: 3 Years ROE 42.5%
Company has a healthy return on capital (ROCE) of 20.9%
Latest quarter profit grew 1251.3% YoY, showing strong momentum
Operating margins have improved to 26.1% from 11.1%
Company comfortably covers its interest (10.3x coverage)
Attractively priced for its growth - PEG of 0.4

CONS

Operating cash flow has been negative in recent years
Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -1.24x)
Free cash flow has been persistently negative
Though reporting repeated profits, the company pays out little dividend (0.0%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	SUNPHARMA	1899.00	37.67	455633.71	0.84	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9100.00	82.59	241576.41	0.33	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4850.00	84.58	184478.41	0.78	566.00	3.28	4921.00	57.32	19.27	33.81
4.	CIPLA	1385.00	33.19	111888.39	0.94	785.55	-39.18	7119.28	4.13	16.00	16.73
5.	ZYDUSLIFE	1121.00	24.78	111820.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
6.	LAURUSLABS	1840.00	90.93	99417.45	0.11	362.07	123.94	2026.31	29.10	18.20	31.50
7.	LUPIN	2111.00	17.46	96528.82	0.85	1416.98	16.01	8276.89	34.28	28.86	29.59
8.	DRREDDY	1154.00	29.89	96322.06	0.69	435.60	-69.10	8099.80	-5.21	13.75	10.63
9.	MANKIND	2328.55	47.09	96179.61	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
10.	AUROPHARMA	1653.30	25.62	95127.23	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
11.	GLENMARK	2427.00	38.10	68495.93	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	AHCL	15.68	29.23	833.42	0.00	82.81	—	875.63	1689.56	21.98	17.81

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	38	24	9	49	33	52	36	55	310
	31	17	9	32	27	38	23	42	251
Operating Profit	7	8	1	17	6	14	12	14	58
OPM %	18.29%	31.11%	6.20%	35.13%	18.74%	26.32%	34.68%	25.10%	18.87%
	0	0	0	0	0	0	0	0	1
Interest	1	1	1	1	1	1	2	1	10
Depreciation	0	0	0	1	0	0	0	0	7
Profit before Tax	6	6	-0	15	5	12	11	13	59
Tax %	31.83%	57.86%	-758.62%	-7.49%	29.20%	25.14%	51.41%	22.36%	18.75%
Net Profit	4	3	-2	17	4	9	5	10	48
	0.41	0.41	-0.83	5.15	2.22	2.22	1.13	2.15	0.09

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	57	113	67	120	176	453
	52	100	51	88	130	355
Operating Profit	6	13	16	33	46	98
OPM %	9.72%	11.11%	23.59%	27.06%	26.14%	21.73%
	0	0	0	0	0	1
Interest	4	4	4	4	4	13
Depreciation	2	2	2	2	1	8
Profit before Tax	-0	7	10	27	41	95
Tax %	-0.00%	16.78%	0.96%	23.69%	31.63%	23.74%
Net Profit	-0	6	10	21	28	72
EPS	-0.09	4.85	6.04	5.15	5.23	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	—

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: 16%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: 68%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: 72%

RETURN ON EQUITY

10 Years:: —
5 Years:: 50%
3 Years:: 43%
Last Year:: 19%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	12	12	16	40	53
	-10	-5	5	41	157
	60	66	75	58	46
Trade Payables	15	25	20	20	39
	8	12	12	23	22
Total Liabilities	85	112	128	181	317
	27	26	27	23	40
	2	4	1	1	10
	27	27	42	50	76
	0	0	39	75	104
Cash & Bank	2	1	2	1	3
	28	54	17	31	83
Total Assets	85	112	128	181	317

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-2	-3	-3	-23	-46
Cash from Investing	-0	-0	-3	3	-28
Cash from Financing	3	2	8	19	76
	1	-1	2	-1	2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
PER SHARE
EPS (₹)	-0.09	4.85	6.04	5.15	5.23
Book Value (₹)	1.30	6.15	13.14	20.18	39.47
Dividend per Share (₹)	0.00	0.00	0.00	0.00	0.00
Cash EPS (₹)	0.14	0.64	0.72	0.56	0.55
PROFITABILITY
Operating Margin %	10.41%	11.11%	23.59%	27.06%	26.14%
Net Margin %	-0.19%	5.16%	14.50%	17.06%	15.76%
ROE %	-6.93%	130.37%	67.99%	40.45%	19.17%
ROCE %	6.42%	15.42%	15.48%	24.83%	22.38%
	-0.13%	5.92%	8.06%	13.27%	11.16%
EFFICIENCY
Debtor Days	130	104	226	173	185
Inventory Days	170	87	188	140	130
Payable Days	128	84	246	97	96
	172	106	169	215	220
FINANCIAL HEALTH
Debt to Equity (x)	40.14x	9.54x	3.86x	0.83x	0.22x
Interest Coverage (x)	0.97x	2.78x	3.33x	7.63x	10.34x
	2.00x	1.97x	2.01x	2.64x	2.57x
GROWTH
Revenue Growth %	0.00%	97.54%	-41.01%	80.65%	46.73%
Operating Profit Growth %	0.00%	114.98%	23.69%	106.87%	41.79%
Net Profit Growth %	0.00%	5503.90%	65.93%	112.47%	35.53%
	0.00%	5503.90%	24.45%	-14.70%	1.62%
VALUATION
P/E (x)	0.00x	0.00x	0.00x	0.00x	2.13x
P/B (x)	0.00x	0.00x	0.00x	0.00x	2.82x
Dividend Yield %	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00x	6.39x	6.00x	3.21x	13.66x

Shareholding Pattern

Numbers in percentages

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	52.68	52.68	52.68	52.68
	0.00	0.23	0.32	1.67
	2.83	4.49	4.60	1.23
Government	0.00	0.00	0.00	0.00
	44.49	42.60	42.40	44.43

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-05

Shareholders meeting

2026-09-05 - Anlon Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 05, 2026. Further, the company has informed the Exchange regarding voting results.

2026-09-05

Shareholders meeting

2026-09-05 - Anlon Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 05, 2026

2026-08-25

Corrigendum

2026-08-25 - Anlon Healthcare Limited has informed the Exchange regarding Corrigendum to Notice of Annual General Meeting to be held on September 05, 2026

2026-08-17

Copy of Newspaper Publication

2026-08-17 - Anlon Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-14

Shareholders meeting

2026-08-14 - Anlon Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 05, 2026

2026-08-14

Monitoring Agency Report

2026-08-14 - Submission of Monitoring Agency Report for the quarter ended June 30, 2026.

2026-08-13

Record Date

2026-08-13 - Anlon Healthcare Limited has informed the Exchange that Record date for the purpose of Annual General Meeting is 28-Aug-2026.

2026-08-13

Outcome of Board Meeting

2026-08-13 - Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on August 13, 2026.

2026-08-13

Others

2026-08-13 - Anlon Healthcare Limited has informed the Exchange about Others

News

Recent coverage and analyst commentary for AHCL

Loading news…

🤖

AI Stock Analyst

Anlon Healthcare Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1899.00

37.67

455633.71

0.84

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9100.00

82.59

241576.41

0.33

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4850.00

84.58

184478.41

0.78

566.00

3.28

4921.00

57.32

19.27

33.81

CIPLA

1385.00

33.19

111888.39

0.94

785.55

-39.18

7119.28

4.13

16.00

16.73

ZYDUSLIFE

1121.00

24.78

111820.18

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

LAURUSLABS

1840.00

90.93

99417.45

0.11

362.07

123.94

2026.31

29.10

18.20

31.50

LUPIN

2111.00

17.46

96528.82

0.85

1416.98

16.01

8276.89

34.28

28.86

29.59

DRREDDY

1154.00

29.89

96322.06

0.69

435.60

-69.10

8099.80

-5.21

13.75

10.63

MANKIND

2328.55

47.09

96179.61

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

AUROPHARMA

1653.30

25.62

95127.23

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

GLENMARK

2427.00

38.10

68495.93

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

AHCL

15.68

29.23

833.42

0.00

82.81

—

875.63

1689.56

21.98

17.81

Jun 2024

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

310

251

Operating Profit

OPM %

18.29%

31.11%

6.20%

35.13%

18.74%

26.32%

34.68%

25.10%

18.87%

Interest

Depreciation

Profit before Tax

-0

Tax %

31.83%

57.86%

-758.62%

-7.49%

29.20%

25.14%

51.41%

22.36%

18.75%

Net Profit

-2

0.41

-0.83

5.15

2.22

1.13

2.15

0.09

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

113

120

176

453

100

130

355

Operating Profit

OPM %

9.72%

11.11%

23.59%

27.06%

26.14%

21.73%

Interest

Depreciation

Profit before Tax

-0

Tax %

-0.00%

16.78%

0.96%

23.69%

31.63%

23.74%

Net Profit

-0

EPS

-0.09

4.85

6.04

5.15

5.23

—

Dividend Payout %

0.00%

—

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

-10

-5

157

Trade Payables

Total Liabilities

112

128

181

317

104

Cash & Bank

Total Assets

112

128

181

317

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

-2

-3

-23

-46

Cash from Investing

-0

-3

-28

Cash from Financing

-1

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

PER SHARE

EPS (₹)

-0.09

4.85

6.04

5.15

5.23

Book Value (₹)

1.30

6.15

13.14

20.18

39.47

Dividend per Share (₹)

0.00

Cash EPS (₹)

0.14

0.64

0.72

0.56

0.55

PROFITABILITY

Operating Margin %

10.41%

11.11%

23.59%

27.06%

26.14%

Net Margin %

-0.19%

5.16%

14.50%

17.06%

15.76%

ROE %

-6.93%

130.37%

67.99%

40.45%

19.17%

ROCE %

6.42%

15.42%

15.48%

24.83%

22.38%

-0.13%

5.92%

8.06%

13.27%

11.16%

EFFICIENCY

Debtor Days

130

104

226

173

185

Inventory Days

170

188

140

130

Payable Days

128

246

172

106

169

215

220

FINANCIAL HEALTH

Debt to Equity (x)

40.14x

9.54x

3.86x

0.83x

0.22x

Interest Coverage (x)

0.97x

2.78x

3.33x

7.63x

10.34x

2.00x

1.97x

2.01x

2.64x

2.57x

GROWTH

Revenue Growth %

0.00%

97.54%

-41.01%

80.65%

46.73%

Operating Profit Growth %

0.00%

114.98%

23.69%

106.87%

41.79%

Net Profit Growth %

0.00%

5503.90%

65.93%

112.47%

35.53%

0.00%

5503.90%

24.45%

-14.70%

1.62%

VALUATION

P/E (x)

0.00x

2.13x

P/B (x)

0.00x

2.82x

Dividend Yield %

0.00%

0.00x

6.39x

6.00x

3.21x

13.66x

Sep 2025

Dec 2025

Mar 2026

Jun 2026

52.68

0.00

0.23

0.32

1.67

2.83

4.49

4.60

1.23

Government

0.00

44.49

42.60

42.40

44.43

Anlon Healthcare Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Anlon Healthcare Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI